CompletedNCT00688844

Nutritional and Neurotransmitter Changes in PKU Subjects on BH4

Studying Disorder of phenylalanin or tyrosine metabolism

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emory University
Principal Investigator: Rani H Singh, PhD, RD
Emory University Department of Human Genetics
Intervention: KuvanTM Therapy(drug)
Enrollment: 58 enrolled
Eligibility: 4 years · All sexes
Timeline: 2008 – 2010

Study locations (2)

Emory Hospital, CIN/ACTSI, Atlanta, Georgia, United States
Emory University Genetics Clinic, Decatur, Georgia, United States

Collaborators

BioMarin Pharmaceutical · Atlanta Clinical and Translational Science Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00688844 on ClinicalTrials.gov

← Back to all trials